Chromium(III) oxide nanoparticles induced remarkable oxidative stress and apoptosis on culture cells

Environmental Toxicology

Volumn 28, Issue 2, 2013, Pages 61-75

  Horie, Masanori ^a   Nishio, Keiko ^a   Endoh, Shigehisa ^a   Kato, Haruhisa ^b   Fujita, Katsuhide ^a   Miyauchi, Arisa ^a   Nakamura, Ayako ^b   Kinugasa, Shinichi ^b   Yamamoto, Kazuhiro ^a   Niki, Etsuo ^a   Yoshida, Yasukazu ^a   Iwahashi, Hitoshi ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Apoptosis; Chromium oxide; Hexavalent chromium; Nanoparticle; Oxidative stress

Indexed keywords

A549 CELLS; ANTIOXIDANT DEFENSE SYSTEM; CASPASE-3 ACTIVATION; CELL VIABILITY; CELLULAR EFFECTS; CELLULAR RESPONSE; CELLULAR UPTAKE; CHROMIUM OXIDES; CULTURE CELLS; CULTURE MEDIUM; CYTOTOXIC; EXTRACELLULAR; FINE PARTICLES; HEXAVALENT CHROMIUM; HUMAN LUNG; KERATINOCYTES; NEW FORMS; ONE DIMENSION; REACTIVE OXYGEN SPECIES; SMALL PARTICLES; TRIVALENT CHROMIUM;

CELL CULTURE; CELL DEATH; CHROMIUM; CHROMIUM COMPOUNDS; CYTOTOXICITY; ENZYME ACTIVITY; INDUSTRIAL APPLICATIONS; OXIDATIVE STRESS;

NANOPARTICLES;

CASPASE 3; CHROMIUM; CHROMIUM OXIDE NANOPARTICLE; NANOPARTICLE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANTIOXIDANT; APOPTOSIS; CATALYST; CHROMIUM; CYTOLOGY; ECOTOXICOLOGY; ENZYME ACTIVITY; HEALTH IMPACT; NANOTECHNOLOGY; OXIDE; OXYGEN; PIGMENT; POLLUTION EFFECT; POLLUTION EXPOSURE; PUBLIC HEALTH; SOLUBILITY; TOXICITY TEST;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; HUMAN; HUMAN CELL; KERATINOCYTE; OXIDATIVE STRESS; PARTICLE SIZE; PRIORITY JOURNAL;

APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; CELL SURVIVAL; CHROMIUM; CHROMIUM COMPOUNDS; CULTURE MEDIA; DNA DAMAGE; GLUTATHIONE; HUMANS; KERATINOCYTES; NANOPARTICLES; OXIDATIVE STRESS; PARTICLE SIZE; REACTIVE OXYGEN SPECIES;

EID: 84872378289     PISSN: 15204081     EISSN: 15227278     Source Type: Journal    
DOI: 10.1002/tox.20695     Document Type: Article

References (35)

1. Anderson ME. 1985. Determination of glutathione and glutathione disulfide in biological samples. Methods Enzymol 113: 548-555.
2. Annunziato L, Amoroso S, Pannaccione A, Cataldi M, Pignataro G, D'Alessio A, Sirabella R, Secondo A, Sibaud L, Di Renzo GF. 2003. Apoptosis induced in neuronal cells by oxidative stress: Role played by caspases and intracellular calcium ions. Toxicol Lett 139: 125-133.
3. Bagchi D, Stohs SJ, Downs BW, Bagchi M, Preuss HG. 2002. Cytotoxicity and oxidative mechanisms of different forms of chromium. Toxicology 180: 5-22.
4. Balamurugan K, Rajaram R, Ramasami T, Narayanan S. 2002. Chromium(III)-induced apoptosis of lymphocytes: Death decision by ROS and Src-family tyrosine kinases. Free Radic Biol Med 33: 1622-1640.
5. Barceloux DG. 1999. Chromium. J Toxicol Clin Toxicol 37: 173-194.
6. Biedermann KA, Landolph JR. 1990. Role of valence state and solubility of chromium compounds on induction of cytotoxicity, mutagenesis, and anchorage independence in diploid human fibroblasts. Cancer Res 50: 7835-7842.
7. Casey A, Herzog E, Lyng FM, Byrne HJ, Chambers G, Davoren M. 2008. Single walled carbon nanotubes induce indirect cytotoxicity by medium depletion in A549 lung cells. Toxicol Lett 179: 78-84.
8. De Flora S, Wetterhahn KE. 1989. Mechanisms of chromium metabolism and genotoxicity. Life Chem Rep 7: 169-244.
9. Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C. 2006. Clonogenic assay of cells in vitro. Nat Protoc 1: 2315-2319.
10. Herzog E, Casey A, Lyng FM, Chambers G, Byrne HJ, Davoren M. 2007. A new approach to the toxicity testing of carbon-based nanomaterials-The clonogenic assay. Toxicol Lett 174: 49-60.
11. Hininger I, Benaraba R, Osman M, Faure H, Marie Roussel A, Anderson RA. 2007. Safety of trivalent chromium complexes: No evidence for DNA damage in human HaCaT keratinocytes. Free Radic Biol Med 42: 1759-1765.
12. Holmes AL, Wise SS, Wise JPSr. 2008. Carcinogenicity of hexavalent chromium. Indian J Med Res 128: 353-372.
13. Horie M, Nishio K, Fujita K, Endoh S, Miyauchi A, Saito Y, Iwahashi H, Yamamoto K, Murayama H, Nakano H, Nanashima N, Niki E, Yoshida Y. 2009a. Protein adsorption of ultrafine metal oxide and its influence on cytotoxicity toward cultured cells. Chem Res Toxicol 22: 543-553.
14. Horie M, Nishio K, Fujita K, Kato H, Nakamura A, Kinugasa S, Endoh S, Miyauchi A, Yamamoto K, Murayama H, Niki E, Iwahashi H, Yoshida Y, Nakanishi J. 2009b. Ultrafine NiO particles induce cytotoxicity in vitro by cellular uptake and subsequent Ni(II) release. Chem Res Toxicol 22: 1415-1426.
15. Horie M, Nishio K, Fujita K, Kato H, Endoh S, Suzuki M, Nakamura A, Miyauchi A, Kinugasa S, Yamamoto K, Iwahashi H, Murayama H, Niki E, Yoshida Y. 2010. Cellular responses by stable and uniform ultrafine titanium dioxide particles in culture-medium dispersions when secondary particle size was 100 nm or less. Toxicol In Vitro 24: 1629-1638.
16. Kato H, Suzuki M, Fujita K, Horie M, Endoh S, Yoshida Y, Iwahashi H, Takahashi K, Nakamura A, Kinugasa S. 2009. Reliable size determination of nanoparticles using dynamic light scattering method for in vitro toxicology assessment. Toxicol In Vitro 23: 927-934.
17. Levina A, Lay PA. 2008. Chemical properties and toxicity of chromium(III) nutritional supplements. Chem Res Toxicol 21: 563-571.
18. Lushchak OV, Kubrak OI, Lozinsky OV, Storey JM, Storey KB, Lushchak VI. 2009a. Chromium(III) induces oxidative stress in goldfish liver and kidney. Aquat Toxicol 93: 45-52.
19. Lushchak OV, Kubrak OI, Torous IM, Nazarchuk TY, Storey KB, Lushchak VI. 2009b. Trivalent chromium induces oxidative stress in goldfish brain. Chemospherea 75: 56-62.
20. Mattagajasingh SN, Misra BR, Misra HP. 2008. Carcinogenic chromium(VI)-induced protein oxidation and lipid peroxidation: Implications in DNA-protein crosslinking. J Appl Toxicol 28: 987-997.
21. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin TT, Yu VL, Miller DK. 1995. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37-43.
22. Robertson NM, Zangrilli J, Fernandes-Alnemri T, Friesen PD, Litwack G, Alnemri ES. 1997. Baculovirus P35 inhibits the glucocorticoid-mediated pathway of cell death. Cancer Res 57: 43-47.
23. Rudolf E, Cervinka M. 2003. Chromium (III) produces distinct type of cell death in cultured cells. Acta Med 46: 139-146.
24. Rudolf E, Cervinka M. 2009. Trivalent chromium activates Rac-1 and Src and induces switch in the cell death mode in human dermal fibroblasts. Toxicol Lett 188: 236-242.
25. Shi XL, Dalal NS. 1989. Chromium (V) and hydroxyl radical formation during the glutathione reductase-catalyzed reduction of chromium (VI). Biochem Biophys Res Commun 163: 627-634.
26. Studer AM, Limbach LK, Van Duc L, Krumeich F, Athanassiou EK, Gerber LC, Moch H, Stark WJ. 2010. Nanoparticle cytotoxicity depends on intracellular solubility: Comparison of stabilized copper metal and degradable copper oxide nanoparticles. Toxicol Lett 197: 169-174.
27. Takahashi S, Yamada M, Kondo T, Sato H, Furuya K, Tanaka I. 1992. Cytotoxicity of nickel oxide particles in rat alveolar macrophages cultured in vitro. J Toxicol Sci 17: 243-251.
28. Tayama S, Nakagawa Y. 2004. Comet assay attempted with silver staining method and manual microscopic analysis using CHO-K1 cells. Ann Rep Tokyo Metr Inst PH 55: 315-318.
29. Urrutia C, Rudolph A, Lermanda MP, Ahumada R. 2008. Assessment of EDTA in chromium (III-VI) toxicity on marine intertidal crab (Petrolisthes laevigatus). Bull Environ Contam Toxicol 80: 526-528.
30. Vincent JB. 2000. The biochemistry of chromium. J Nutr 130: 715-718.
31. Vincent JB. 2004. Recent developments in the biochemistry of chromium(III). Biol Trace Elem Res 99: 1-16.
32. Wise SS, Holmes AL, Ketterer ME, Hartsock WJ, Fomchenko E, Katsifis S, Thompson WD, Wise JPSr. 2004. Chromium is the proximate clastogenic species for lead chromate-induced clastogenicity in human bronchial cells. Mutat Res 560: 79-89.
33. Xie H, Holmes AL, Wise SS, Gordon N, Wise JPSr. 2004. Lead chromate-induced chromosome damage requires extracellular dissolution to liberate chromium ions but does not require particle internalization or intracellular dissolution. Chem Res Toxicol 17: 1362-1367.
34. Zhitkovich A. 2005. Importance of chromium-DNA adducts in mutagenicity and toxicity of chromium(VI). Chem Res Toxicol 18: 3-11.
35. Zhitkovich A, Song Y, Quievryn G, Voitkun VA. 2001. Non-oxidative mechanisms are responsible for the induction of mutagenesis by reduction of Cr(VI) with cysteine: Role of ternary DNA adducts in Cr(III)-dependent mutagenesis. Biochemistry 40: 549-560.